Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Dido gene expression alterations are implicated in the induction of hematological myeloid neoplasms.

Fütterer A, Campanero MR, Leonardo E, Criado LM, Flores JM, Hernández JM, San Miguel JF, Martínez-A C.

J Clin Invest. 2005 Sep;115(9):2351-62. Epub 2005 Aug 25.

2.

Deletions of chromosome 20q and the pathogenesis of myeloproliferative disorders.

Asimakopoulos FA, Green AR.

Br J Haematol. 1996 Nov;95(2):219-26. Review.

PMID:
8904873
3.

Molecular bases of myelodysplastic syndromes: lessons from animal models.

Komeno Y, Kitaura J, Kitamura T.

J Cell Physiol. 2009 Jun;219(3):529-34. doi: 10.1002/jcp.21739. Review.

PMID:
19259975
4.

Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci.

Johansson B, Mertens F, Mitelman F.

Genes Chromosomes Cancer. 1993 Dec;8(4):205-18. Review.

PMID:
7512363
6.

The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.

Lo Coco F, Pisegna S, Diverio D.

Haematologica. 1997 May-Jun;82(3):364-70. Review.

7.

Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS.

Leone G, Voso MT, Teofili L, Lübbert M.

Clin Immunol. 2003 Oct;109(1):89-102. Review.

PMID:
14585280
8.

The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.

Michiels JJ, De Raeve H, Berneman Z, Van Bockstaele D, Hebeda K, Lam K, Schroyens W.

Semin Thromb Hemost. 2006 Jun;32(4 Pt 2):307-40. Review.

PMID:
16810609
9.

5q- myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics.

Eisenmann KM, Dykema KJ, Matheson SF, Kent NF, DeWard AD, West RA, Tibes R, Furge KA, Alberts AS.

Oncogene. 2009 Oct 1;28(39):3429-41. doi: 10.1038/onc.2009.207. Epub 2009 Jul 13. Review.

PMID:
19597464
10.

Deletion (11)(q13) as the sole anomaly in myeloid malignancies: four new cases and a short review.

Panani AD, Pappa V, Papageorgiou S, Stamatelli F, Raptis SA.

Ann Hematol. 2004 Mar;83(3):153-5. Epub 2003 Dec 10. Review.

PMID:
15064863
11.

5q-, twenty-five years later: a synopsis.

Van den Berghe H, Michaux L.

Cancer Genet Cytogenet. 1997 Mar;94(1):1-7. Review.

PMID:
9078284
12.

Mutational analyses of the AML1 gene in patients with myelodysplastic syndrome.

Imai O, Kurokawa M, Izutsu K, Hangaishi A, Maki K, Ogawa S, Chiba S, Mitani K, Hirai H.

Leuk Lymphoma. 2002 Mar;43(3):617-21. Review.

PMID:
12002768
13.

Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.

Hall J, Foucar K.

Int J Lab Hematol. 2010 Dec;32(6 Pt 2):559-71. doi: 10.1111/j.1751-553X.2010.01251.x. Review.

PMID:
20670271
14.

De novo myelodysplastic syndrome (MDS) with deletion of the long arm of chromosome 20: a subtype of MDS with distinct hematological and prognostic features?

Wattel E, Laï JL, Hebbar M, Preudhomme C, Grahek D, Morel P, Bauters F, Fenaux P.

Leuk Res. 1993 Nov;17(11):921-6. Review.

PMID:
8231232
15.

Clinical and morphological features of paediatric myelodysplastic syndromes: a review of 34 cases.

Polychronopoulou S, Panagiotou JP, Kossiva L, Mavrou A, Anagnostou D, Haidas S.

Acta Paediatr. 2004 Aug;93(8):1015-23. Review.

PMID:
15456186
16.

[TET2 gene in hematological diseases].

Li S, Wang XQ.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Jun;22(3):836-41. doi: 10.7534/j.issn.1009-2137.2014.03.049. Review. Chinese.

PMID:
24989305
17.

Mouse models of myelodysplastic syndromes.

Beachy SH, Aplan PD.

Hematol Oncol Clin North Am. 2010 Apr;24(2):361-75. doi: 10.1016/j.hoc.2010.02.002. Review.

18.

The biology and clinical impact of genetic lesions in myeloid malignancies.

Lindsley RC, Ebert BL.

Blood. 2013 Nov 28;122(23):3741-8. doi: 10.1182/blood-2013-06-460295. Epub 2013 Aug 16. Review.

19.

Tumor suppressor gene inactivation in myeloid malignancies.

Wong JC, Le Beau MM, Shannon K.

Best Pract Res Clin Haematol. 2008 Dec;21(4):601-14. doi: 10.1016/j.beha.2008.09.001. Review.

PMID:
19041599
20.

Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?

Beurlet S, Chomienne C, Padua RA.

Haematologica. 2013 Jan;98(1):10-22. doi: 10.3324/haematol.2012.069385. Epub 2012 Oct 12. Review.

Items per page

Supplemental Content

Write to the Help Desk